CEO of VASRO GmbH

Quick Contact

CEO, Pharma and Biotech sectors

Dr. Javad Vaseghi

At the helm of VASRO GmbH stands a leader whose expertise and strategic acumen have been instrumental in propelling the firm to the forefront of the industry. Dr. Javad Vaseghi, the Founder and Chief Executive Officer, brings a unique blend of scientific prowess and financial proficiency that sets him apart as a true trailblazer in the realm of equity research and strategic analysis.

Experience & Activities

Dr. Javad Vaseghi is the driving force behind VASRO GmbH, bringing a unique blend of scientific expertise and financial acumen to the firm. With a Ph.D. in Natural Sciences focused on Biochemistry from the University of Bielefeld, Germany, Dr. Vaseghi has an extensive background in life sciences and finance. His professional experience includes roles as an equity analyst at FMR Frankfurt am Main Research and as a manager in regulatory affairs for the pharmaceutical industry in Calw.

Before founding VASRO GmbH, Dr. Vaseghi provided valuable analytical insights and strategic recommendations to investors and clients, including Evotec, MorphoSys, BRAIN Biotech, Vivoryon Therapeutics, and Marinomed. His work involved developing sophisticated financial models, conducting independent company valuations, and delivering comprehensive investment recommendations during his tenure at FMR Frankfurt am Main Research.

Dr. Vaseghi’s expertise spans molecular biology, biochemistry, and regulatory affairs, combined with a strong proficiency in financial analysis. As CEO of VASRO GmbH, his leadership and vision have been essential in building the firm’s reputation for delivering high-quality, tailored equity analysis and consulting services. With a focus on excellence and innovation, Dr. Vaseghi continues to drive the strategic direction and overall operations of the firm, ensuring the success of its clients.